Psoriatic Arthritis
Conference Coverage
PsA prediction tool approaches clinical utility
A tool to identify patients with psoriasis at high risk of psoriatic arthritis appears near to clinical application.
News
Nearly 12% of PsA patients need musculoskeletal surgery
Higher levels of joint damage increased the risk for disease-related surgical procedures.
News
First Humira biosimilar launches in U.S.
Amgen’s Amjevita will be offered at 5% and 55% below Humira’s list price, but patients may not benefit from the more significant discount.
News
Fluorescence-optical imaging may detect preclinical PsA
Identification of microscopic blood vessel changes may point to psoriatic arthritis before clinical symptoms appear.
Opinion
75 years: A look back on the fascinating history of methotrexate and folate antagonists
Dr. David Warmflash recounts how the meandering path of early research into chemotherapy for hematologic malignancies later led to methotrexate’s...
News
Psoriasis, psoriatic arthritis show distinctive skin microbiomes
No significant microbiome differences were noted between lesional and nonlesional skin swab samples from patients with psoriasis and psoriatic...
News
Teamwork guides cardio-rheumatology clinics that care for unique patient population
Cardio-rheumatology programs are “the newest child” in a series of cardiology offshoots focusing on different populations, and such clinics aim to...
News
Topical psoriasis treatments
When using topical treatments, combination therapy is generally more effective than monotherapy for psoriasis, especially for plaque psoriasis, Dr...
News
Cardiovascular risk score multipliers suggested for rheumatic diseases
Guidelines could tailor cardiovascular risk scores by using a multiplier of 2.5 for systemic sclerosis, 2.0 for lupus, and 1.5 for any other...
News
FDA will review pediatric indication for roflumilast cream
The indication under review is for treating psoriasis in children aged 2-11 years.